Advertisement

Topics

Xcyte Therapies Incorporated Company Profile

03:40 EST 18th November 2017 | BioPortfolio

Xcyte Therapies, Inc., a Seattle-based biotechnology company, is developing and commercializing novel cell-based or cellular therapeutic products that harness the power of the immune system to treat cancer and many infectious diseases. It was founded in 1996 by Ron Berenson, MD, a biotechnology veteran and founder of CellPro. Xcyte Therapies has an experienced management team with a proven track record of developing and commercializing biopharmaceutical products. Currently, the company has 60 employees and occupies approximately 20,000 square feet that includes office and laboratory space as well as a state of the art manufacturing facility.

Xcyte Therapies is initially targeting its first product to treat cancers that respond to therapeutic agents that activate the immune system. These types of cancer include, but are not limited to, kidney cancer, prostate cancer, non-Hodgkin's lymphoma (NHL), leukemia, and multiple myeloma.

Location

1124 Columbia Street, Suite 130
Seattle
Washington
98104
United States of America

Contact

Phone: (206) 262 6200
Fax: (206) 262 0900
Email: bd@xcytetherapies.com


News Articles [148 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

How do we achieve optimal sequencing of therapies in CLL?

Dr Ysebaert speaks at the 'Defining treatment strategies for CLL & FL in the era of targeted therapies' symposium at EHA 2017 about achieving optimal sequencing of therapies in CLL. He also discusses...

Combining immune-based therapies with TKIs in melanomas

Prof Robert speaks with ecancer at WIN 2017 about tackling class-associated toxicity and drug resistance with combination therapies based on tyrosine kinase inhibition. Intralesional oncolytic the...

Chimeric antigen receptor T-cell therapies for lymphoma

Cell-based immunotherapies are showing great promise in the treatment of even the most treatment-refractory of haematological malignancies. Herein, Jennifer Brudno and James Kochenderfer review the re...

Patient adherence to oral therapies

Dr Ginah Nightingale talks to ecancer at SIOG 2017 in Warsaw. She discusses the adherence of oral therapies by patients. Dr Nightingale suggests that by observing their commitment to other therapies...

Aegis Therapies Hires New CFO to Help Lead Company Through Next Growth Phase

Plano, TX (PRWEB) September 18, 2017 Aegis Therapies, a national leader in rehabilitation and wellness services has recently expande...

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers ...

Brain Cancer Like McCain's Has Hundreds Of Experimental Therapies (With Little Success)

Researchers are exploring countless possible therapies for glioblastoma--because none have shown much promise yet.

PubMed Articles [561 Associated PubMed Articles listed on BioPortfolio]

Mind-Body Therapies in Cancer: What Is the Latest Evidence?

Many people living with cancer use complementary therapies, and some of the most popular are mind-body therapies (MBTs), including relaxation and imagery, hypnosis, yoga, meditation, tai chi and qigon...

Autism and Mind-Body Therapies: A Systematic Review.

Mind-body therapies are often used by people with autism spectrum disorders (ASD). However, there has been little examination into which types of mind-body therapies have been investigated for people ...

"Monoclonal antibodies in the treatment of MS: emergence of B-cell targeted therapies".

Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, and one of the most common causes of disability in young adults. Over the last decade, new disease modifying therapies have rapidl...

Palliative Therapies for Congenital Heart Disease with Ductus Dependent Pulmonary Circulation.

In neonates, the management of ductus dependent pulmonary circulation is challenging. There have been three palliative therapies for this lesion: the modified Blalock-Taussig shunt, ductal stenting an...

Mental Health Wellness and Biofield Therapies: An Integrative Review.

Biofield therapies such as Healing Touch and Reiki increase relaxation, decrease anxiety and stress, and improve mood. Understanding the efficacy of these therapies in terms of mental health wellness ...

Clinical Trials [1354 Associated Clinical Trials listed on BioPortfolio]

Effect of Complementary and Alternative Medicine on Pain Among Inpatients

The proposed study has 3 aims: 1) quantitatively describe a model for delivering complementary and alternative medicine (CAM) therapies to understand the selection of patients and CAM ther...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

Dysphagia After Different Swallowing Therapies

Dysphagia after stroke is associated to increased pulmonary complications and mortality. The swallowing therapies could decrease the pulmonary complications and improve the quality of life...

Outcome Analysis of POEM and Endoluminal Therapies

Evaluation of current and newly developed endoluminal therapies in the management of Upper and Lower GI conditions.

Functional Restoration and Integrative Therapies in Service Members With Neuromusculoskeletal Injury

This study will (1) compare the effectiveness of standard rehabilitative pain care with complementary and integrative pain therapies; (2) identify subgroups of patients who do and do not r...

Companies [828 Associated Companies listed on BioPortfolio]

Xcyte Therapies Incorporated

Xcyte Therapies, Inc., a Seattle-based biotechnology company, is developing and commercializing novel cell-based or cellular therapeutic products that harness the power of the immune system to treat c...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

Toler RX Incorporated

TolerRx, Inc. is an emerging biopharmaceutical enterprise specializing in the discovery, development, and commercial launch of a novel class of therapies that induce and/or maintain immunological tole...

More Information about "Xcyte Therapies Incorporated" on BioPortfolio

We have published hundreds of Xcyte Therapies Incorporated news stories on BioPortfolio along with dozens of Xcyte Therapies Incorporated Clinical Trials and PubMed Articles about Xcyte Therapies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xcyte Therapies Incorporated Companies in our database. You can also find out about relevant Xcyte Therapies Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record